TNFSF11 and hyperinsulinemic hypoglycemia, familial, 4: However, it has no beneficial effect on disease progression in patients with AR RANKL deficiency, due to the stromal origin of the defect, with insufficient donor stromal precursors or mesenchymal stem cells.